𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTD

✍ Scribed by Chor Sang Chim, Albert Kwok Wai Lie, Eric Yuk Tat Chan, Herman Sung Yu Liu, Ching Wa Lau, Sze Fai Yip, Joycelyn Sim, Thomas Shek-Kong Wan, Edmond Shiu-Kwan Ma, Raymond Liang, Eric Tse, Yok-Lam Kwong


Book ID
119913618
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
243 KB
Volume
5
Category
Article
ISSN
1756-8722

No coin nor oath required. For personal study only.